Found: 15
Select item for more details and to access through your institution.
Efficacy and safety of adalimumab in Chinese patients with moderately to severely active Crohn's disease: results from a randomized trial.
- Published in:
- Therapeutic Advances in Gastroenterology, 2020, v. 13, p. 1, doi. 10.1177/1756284820938960
- By:
- Publication type:
- Article
Adalimumab Reduces Extraintestinal Manifestations in Patients with Crohn's Disease: A Pooled Analysis of 11 Clinical Studies.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Efficacy and Safety of Dose Escalation to Adalimumab 80 mg Every Other Week in Japanese Patients with Crohn’s Disease Who Lost Response to Maintenance Therapy.
- Published in:
- Inflammatory Intestinal Diseases, 2018, v. 2, n. 4, p. 228, doi. 10.1159/000486786
- By:
- Publication type:
- Article
The effects of concomitant immunomodulators on the pharmacokinetics, efficacy and safety of adalimumab in paediatric patients with Crohn's disease: a post hoc analysis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 49, n. 2, p. 155, doi. 10.1111/apt.15054
- By:
- Publication type:
- Article
Four-Year Maintenance Treatment With Adalimumab in Patients with Moderately to Severely Active Ulcerative Colitis: Data from ULTRA 1, 2, and 3.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2014, v. 109, n. 11, p. 1771, doi. 10.1038/ajg.2014.242
- By:
- Publication type:
- Article
When Meta-Analysis Misleads.
- Published in:
- 2011
- By:
- Publication type:
- Letter
Efficacy and Safety of Adalimumab by Disease Duration: Analysis of Pooled Data From Crohn's Disease Studies.
- Published in:
- Journal of Crohn's & Colitis, 2019, v. 13, n. 6, p. 725, doi. 10.1093/ecco-jcc/jjy223
- By:
- Publication type:
- Article
Efficacy of Adalimumab for Treatment of Perianal Fistula in Children with Moderately to Severely Active Crohn's Disease: Results from IMAgINE 1 and IMAgINE 2.
- Published in:
- Journal of Crohn's & Colitis, 2018, v. 12, n. 10, p. 1249, doi. 10.1093/ecco-jcc/jjy087
- By:
- Publication type:
- Article
Clinical Benefit of Long-Term Adalimumab Treatment in Patients With Crohn’s Disease Following Loss of Response or Intolerance to Infliximab: 96-Week Efficacy Data From GAIN/ADHERE Trials.
- Published in:
- Journal of Crohn's & Colitis, 2018, v. 12, n. 8, p. 930, doi. 10.1093/ecco-jcc/jjy050
- By:
- Publication type:
- Article
Effect of Adalimumab on Clinical Outcomes and Health-related Quality of Life Among Patients With Ulcerative Colitis in a Clinical Practice Setting: Results From InspirADA.
- Published in:
- Journal of Crohn's & Colitis, 2017, v. 11, n. 11, p. 1317, doi. 10.1093/ecco-jcc/jjx093
- By:
- Publication type:
- Article
Characterisation of Mucosal Healing with Adalimumab Treatment in Patients with Moderately to Severely Active Crohn's Disease: Results from the EXTEND Trial.
- Published in:
- Journal of Crohn's & Colitis, 2017, v. 11, n. 4, p. 425, doi. 10.1093/ecco-jcc/jjw178
- By:
- Publication type:
- Article
Efficacy and safety of adalimumab in Chinese patients with moderately to severely active Crohn's disease: results from a randomized trial.
- Published in:
- Therapeutic Advances in Cardiovascular Disease, 2020, p. 1, doi. 10.1177/1756284820938960
- By:
- Publication type:
- Article
Nasal Pathophysiology and Its Relationship to the Female Ovarian Hormones.
- Published in:
- Journal of Otolaryngology -- Head & Neck Surgery, 2008, v. 37, n. 4, p. 540, doi. 10.2310/7070.2008.0102
- By:
- Publication type:
- Article
Long-term safety and efficacy of adalimumab for intestinal Behçet's disease in the open label study following a phase 3 clinical trial.
- Published in:
- Intestinal Research, 2017, v. 15, n. 3, p. 395, doi. 10.5217/ir.2017.15.3.395
- By:
- Publication type:
- Article
Adalimumab induction and maintenance therapy achieve clinical remission and response in Chinese patients with Crohn's disease.
- Published in:
- Intestinal Research, 2016, v. 14, n. 2, p. 152, doi. 10.5217/ir.2016.14.2.152
- By:
- Publication type:
- Article